Nuveen LLC Buys Shares of 179,313 Plexus Corp. $PLXS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Nuveen LLC acquired a new position in Plexus Corp. (NASDAQ:PLXS - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 179,313 shares of the technology company's stock, valued at approximately $22,975,000. Nuveen LLC owned approximately 0.66% of Plexus at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Aquatic Capital Management LLC raised its holdings in Plexus by 134.0% in the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock worth $37,000 after purchasing an additional 134 shares in the last quarter. Versant Capital Management Inc raised its holdings in Plexus by 1,000.0% in the first quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock worth $61,000 after purchasing an additional 430 shares in the last quarter. TD Private Client Wealth LLC raised its holdings in Plexus by 185.6% in the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company's stock worth $66,000 after purchasing an additional 334 shares in the last quarter. N.E.W. Advisory Services LLC bought a new position in Plexus in the first quarter worth $87,000. Finally, Blue Trust Inc. raised its holdings in Plexus by 49.2% in the first quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock worth $108,000 after purchasing an additional 279 shares in the last quarter. Institutional investors own 94.45% of the company's stock.

Plexus Stock Up 5.1%

Shares of NASDAQ PLXS traded up $6.71 during trading on Friday, reaching $137.26. The company had a trading volume of 151,618 shares, compared to its average volume of 180,705. Plexus Corp. has a 12-month low of $103.43 and a 12-month high of $172.89. The stock has a market cap of $3.70 billion, a PE ratio of 23.38 and a beta of 0.80. The business's 50-day moving average is $132.44 and its 200 day moving average is $130.07. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The firm had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. During the same period in the prior year, the firm posted $1.45 earnings per share. The company's quarterly revenue was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, equities analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Insider Activity at Plexus

In related news, insider Michael J. Running sold 646 shares of the stock in a transaction on Friday, May 30th. The stock was sold at an average price of $130.05, for a total transaction of $84,012.30. Following the sale, the insider directly owned 630 shares of the company's stock, valued at $81,931.50. This trade represents a 50.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Patrick John Jermain sold 2,178 shares of the stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $130.42, for a total value of $284,054.76. Following the sale, the chief financial officer directly owned 23,459 shares in the company, valued at $3,059,522.78. This trade represents a 8.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 12,484 shares of company stock valued at $1,626,335 over the last three months. 1.76% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Wall Street Zen downgraded Plexus from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 16th. Stifel Nicolaus set a $140.00 target price on Plexus in a research note on Thursday, July 24th. Sidoti raised Plexus from a "neutral" rating to a "buy" rating and increased their target price for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Needham & Company LLC cut their target price on Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a research note on Thursday, July 24th. Finally, Benchmark reissued a "buy" rating and issued a $160.00 target price on shares of Plexus in a research note on Wednesday, June 4th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $152.00.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.